Seres Therapeutics, Inc. (MCRB) Social Stream



Seres Therapeutics, Inc. (MCRB): $6.74

-0.38 (-5.34%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MCRB to Watchlist
Sign Up

Industry: Biotech


Ranked

of 506

in industry

Seres Therapeutics Inc (MCRB) Price Targets From Analysts

Use the tables below to see what analysts covering Seres Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
7 $32 $16 $23 $6.64 246.39%

The Trend in the Analyst Price Target


MCRB's average price target has moved down $14.5 over the prior 37 weeks.

MCRB reports an average of 91.1% for its upside potential over the past 16 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-04 7 32.0 16.00 23.00 6.680 244.31%
2021-08-28 7 32.0 16.00 23.00 6.250 268%
2021-08-14 7 32.0 16.00 23.00 6.650 245.86%
2021-08-07 7 32.0 16.00 23.00 6.980 229.51%
2021-08-05 7 32.0 16.00 23.00 6.980 229.51%
2021-08-01 7 32.0 16.00 23.57 7.100 231.97%
2021-07-24 7 32.0 16.00 23.57 7.390 218.94%
2021-07-17 7 46.0 24.00 36.57 20.800 75.82%
2021-07-10 7 46.0 24.00 36.57 21.300 71.69%
2021-07-03 7 46.0 24.00 36.57 21.170 72.74%
2021-06-26 7 47.0 24.00 38.00 23.570 61.22%
2021-06-13 7 47.0 24.00 38.00 20.540 85%
2021-06-05 7 47.0 24.00 38.00 18.770 102.45%
2021-05-22 7 47.0 24.00 38.00 21.280 78.57%
2021-05-15 7 47.0 24.00 38.00 22.540 68.59%
2021-05-08 7 47.0 24.00 38.00 20.730 83.31%
2021-04-25 7 47.0 24.00 35.86 20.460 75.27%
2021-04-17 7 47.0 24.00 35.86 20.730 72.99%
2021-04-10 7 47.0 24.00 37.57 20.580 82.56%
2021-04-03 7 47.0 24.00 37.57 20.450 83.72%
2021-03-20 7 47.0 24.00 37.57 21.450 75.15%
2021-03-13 7 47.0 24.00 37.57 21.370 75.81%
2021-03-06 7 49.0 24.00 37.86 19.060 98.64%
2021-02-27 7 49.0 24.00 37.50 19.040 96.95%
2021-02-20 7 49.0 24.00 37.50 24.450 53.37%
2021-02-13 7 49.0 24.00 37.50 25.940 44.56%
2021-02-06 7 49.0 24.00 37.50 27.040 38.68%
2021-01-30 7 49.0 24.00 37.50 23.750 57.89%
2021-01-23 7 49.0 24.00 37.50 24.050 55.93%
2021-01-16 7 49.0 24.00 37.50 24.480 53.19%
2021-01-09 7 49.0 24.00 37.50 27.600 35.87%
2021-01-02 7 49.0 24.00 37.50 24.500 53.06%
2020-12-26 7 49.0 24.00 37.50 24.280 54.45%
2020-12-19 7 49.0 24.00 37.50 24.120 55.47%
2020-12-10 7 49.0 24.00 37.50 25.040 49.76%
2020-12-07 7 49.0 24.00 37.50 25.250 48.51%
2020-11-28 7 49.0 24.00 37.50 29.010 29.27%
2020-11-09 7 49.0 24.00 37.50 33.240 12.82%
2020-10-24 7 42.0 24.00 33.93 30.155 12.52%
2020-09-18 7 42.0 24.00 33.21 25.650 29.47%
2020-09-17 7 41.0 24.00 32.64 26.860 21.52%
2020-08-17 7 41.0 24.00 33.50 NA NA%
2020-08-10 6 41.0 24.00 32.42 NA NA%
2020-07-28 6 12.5 4.00 8.08 NA NA%
2020-06-13 6 12.5 3.75 8.04 NA NA%
2020-05-16 6 12.5 3.75 8.04 NA NA%

MCRB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 3 4 1 0 0 9

The Trend in the Broker Recommendations


Over the past 13 months, MCRB's average broker recommendation rating worsened by 0.5.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • MCRB has a higher upside potential (average analyst target price relative to current price) than 93.13% of all US stocks.
  • The variance in analysts' estimates of MCRB is lower than 12.5% of all US stocks.
  • The average analyst price target of MCRB is higher than 28.42% of stocks in the mid market cap category.
  • MCRB has a greater number of analysts covering the stock than 69.75% of Pharmaceutical Products stocks.

Stocks similar to Seres Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SYBX, SCYX and AVRO.

Is MCRB a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7285 seconds.